ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Biosuperior Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-22D13086
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Biosuperior Market Research Report 2023
BUY CHAPTERS

Global Biosuperior Market Research Report 2025

Code: QYRE-Auto-22D13086
Report
May 2025
Pages:78
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
F. Hoffmann-La Roche AG
Merck and Co.
Sanofi
Servier
Porton Biopharma
Eli Lily And Company
Novo Nordisk
Biogen
CSL Behring GmbH
TEVA

Biosuperior Market Size

The global market for Biosuperior was valued at US$ 987 million in the year 2024 and is projected to reach a revised size of US$ 1800 million by 2031, growing at a CAGR of 9.1% during the forecast period.

Biosuperior Market

Biosuperior Market

Biobetters, also known as biosuperiors, are recombinant protein drugs from an identical class as a present set of biopharmaceuticals is not similar to the source. It is neither a wholly novel medicine nor a generic version of an old drug. It is a biological product designed to increase clinical efficacy while also improving tolerance and lowering dosing/administration frequency.
According to the Global Use of Medicines 2023 released by IQVIA Institute, the global drug expenditure in 2022 was about US$1.48 trillion (excluding COVID vaccine and treatment-related expenses), and it is predicted to grow at a rate of 3%-6% in the next few years. In terms of drug expenditure, this number in China was about 166 billion dollars in 2022. It is expected that the expenditure on medicines will increase in the next few years. From the perspective of demand, the trend of population aging, the increase of residents’ wealth and the improvement of health awareness will drive the demand for medicines.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Biosuperior, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biosuperior.
The Biosuperior market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Biosuperior market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Biosuperior manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Biosuperior Market Report

Report Metric Details
Report Name Biosuperior Market
Accounted market size in year US$ 987 million
Forecasted market size in 2031 US$ 1800 million
CAGR 9.1%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company F.Hoffmann-La Roche AG, Merck and Co., Sanofi, SERVIER, Porton Biopharma, Eli Lily and Company, Novo Nordisk, Biogen, CSL Behring GmbH, Teva
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Biosuperior manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Biosuperior in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Biosuperior Market growing?

Ans: The Biosuperior Market witnessing a CAGR of 9.1% during the forecast period 2025-2031.

What is the Biosuperior Market size in 2031?

Ans: The Biosuperior Market size in 2031 will be US$ 1800 million.

Who are the main players in the Biosuperior Market report?

Ans: The main players in the Biosuperior Market are F.Hoffmann-La Roche AG, Merck and Co., Sanofi, SERVIER, Porton Biopharma, Eli Lily and Company, Novo Nordisk, Biogen, CSL Behring GmbH, Teva

What are the Application segmentation covered in the Biosuperior Market report?

Ans: The Applications covered in the Biosuperior Market report are Cancer, Diabetes, Genetic Disease, Neurological Disorders, Others

What are the Type segmentation covered in the Biosuperior Market report?

Ans: The Types covered in the Biosuperior Market report are G-CSF Biobetters, Insulin Biobetters, Erythropoietin Biobetters, Monoclonal Antibodies Biobetters, Others

Recommended Reports

Biopharma Support

Biopharma Packaging

Biopharmaceutical Ingredients

1 Biosuperior Market Overview
1.1 Product Definition
1.2 Biosuperior by Type
1.2.1 Global Biosuperior Market Value Comparison by Type (2024 VS 2031)
1.2.2 G-CSF Biobetters
1.2.3 Insulin Biobetters
1.2.4 Erythropoietin Biobetters
1.2.5 Monoclonal Antibodies Biobetters
1.2.6 Others
1.3 Biosuperior by Application
1.3.1 Global Biosuperior Market Value by Application (2024 VS 2031)
1.3.2 Cancer
1.3.3 Diabetes
1.3.4 Genetic Disease
1.3.5 Neurological Disorders
1.3.6 Others
1.4 Global Biosuperior Market Size Estimates and Forecasts
1.4.1 Global Biosuperior Revenue 2020-2031
1.4.2 Global Biosuperior Sales 2020-2031
1.4.3 Global Biosuperior Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Biosuperior Market Competition by Manufacturers
2.1 Global Biosuperior Sales Market Share by Manufacturers (2020-2025)
2.2 Global Biosuperior Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Biosuperior Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Biosuperior, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Biosuperior, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Biosuperior, Product Type & Application
2.7 Global Key Manufacturers of Biosuperior, Date of Enter into This Industry
2.8 Global Biosuperior Market Competitive Situation and Trends
2.8.1 Global Biosuperior Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Biosuperior Players Market Share by Revenue
2.8.3 Global Biosuperior Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Biosuperior Market Scenario by Region
3.1 Global Biosuperior Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Biosuperior Sales by Region: 2020-2031
3.2.1 Global Biosuperior Sales by Region: 2020-2025
3.2.2 Global Biosuperior Sales by Region: 2026-2031
3.3 Global Biosuperior Revenue by Region: 2020-2031
3.3.1 Global Biosuperior Revenue by Region: 2020-2025
3.3.2 Global Biosuperior Revenue by Region: 2026-2031
3.4 North America Biosuperior Market Facts & Figures by Country
3.4.1 North America Biosuperior Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Biosuperior Sales by Country (2020-2031)
3.4.3 North America Biosuperior Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Biosuperior Market Facts & Figures by Country
3.5.1 Europe Biosuperior Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Biosuperior Sales by Country (2020-2031)
3.5.3 Europe Biosuperior Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Biosuperior Market Facts & Figures by Region
3.6.1 Asia Pacific Biosuperior Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Biosuperior Sales by Region (2020-2031)
3.6.3 Asia Pacific Biosuperior Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Biosuperior Market Facts & Figures by Country
3.7.1 Latin America Biosuperior Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Biosuperior Sales by Country (2020-2031)
3.7.3 Latin America Biosuperior Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Biosuperior Market Facts & Figures by Country
3.8.1 Middle East and Africa Biosuperior Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Biosuperior Sales by Country (2020-2031)
3.8.3 Middle East and Africa Biosuperior Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Biosuperior Sales by Type (2020-2031)
4.1.1 Global Biosuperior Sales by Type (2020-2025)
4.1.2 Global Biosuperior Sales by Type (2026-2031)
4.1.3 Global Biosuperior Sales Market Share by Type (2020-2031)
4.2 Global Biosuperior Revenue by Type (2020-2031)
4.2.1 Global Biosuperior Revenue by Type (2020-2025)
4.2.2 Global Biosuperior Revenue by Type (2026-2031)
4.2.3 Global Biosuperior Revenue Market Share by Type (2020-2031)
4.3 Global Biosuperior Price by Type (2020-2031)
5 Segment by Application
5.1 Global Biosuperior Sales by Application (2020-2031)
5.1.1 Global Biosuperior Sales by Application (2020-2025)
5.1.2 Global Biosuperior Sales by Application (2026-2031)
5.1.3 Global Biosuperior Sales Market Share by Application (2020-2031)
5.2 Global Biosuperior Revenue by Application (2020-2031)
5.2.1 Global Biosuperior Revenue by Application (2020-2025)
5.2.2 Global Biosuperior Revenue by Application (2026-2031)
5.2.3 Global Biosuperior Revenue Market Share by Application (2020-2031)
5.3 Global Biosuperior Price by Application (2020-2031)
6 Key Companies Profiled
6.1 F.Hoffmann-La Roche AG
6.1.1 F.Hoffmann-La Roche AG Company Information
6.1.2 F.Hoffmann-La Roche AG Description and Business Overview
6.1.3 F.Hoffmann-La Roche AG Biosuperior Sales, Revenue and Gross Margin (2020-2025)
6.1.4 F.Hoffmann-La Roche AG Biosuperior Product Portfolio
6.1.5 F.Hoffmann-La Roche AG Recent Developments/Updates
6.2 Merck and Co.
6.2.1 Merck and Co. Company Information
6.2.2 Merck and Co. Description and Business Overview
6.2.3 Merck and Co. Biosuperior Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Merck and Co. Biosuperior Product Portfolio
6.2.5 Merck and Co. Recent Developments/Updates
6.3 Sanofi
6.3.1 Sanofi Company Information
6.3.2 Sanofi Description and Business Overview
6.3.3 Sanofi Biosuperior Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Sanofi Biosuperior Product Portfolio
6.3.5 Sanofi Recent Developments/Updates
6.4 SERVIER
6.4.1 SERVIER Company Information
6.4.2 SERVIER Description and Business Overview
6.4.3 SERVIER Biosuperior Sales, Revenue and Gross Margin (2020-2025)
6.4.4 SERVIER Biosuperior Product Portfolio
6.4.5 SERVIER Recent Developments/Updates
6.5 Porton Biopharma
6.5.1 Porton Biopharma Company Information
6.5.2 Porton Biopharma Description and Business Overview
6.5.3 Porton Biopharma Biosuperior Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Porton Biopharma Biosuperior Product Portfolio
6.5.5 Porton Biopharma Recent Developments/Updates
6.6 Eli Lily and Company
6.6.1 Eli Lily and Company Company Information
6.6.2 Eli Lily and Company Description and Business Overview
6.6.3 Eli Lily and Company Biosuperior Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Eli Lily and Company Biosuperior Product Portfolio
6.6.5 Eli Lily and Company Recent Developments/Updates
6.7 Novo Nordisk
6.7.1 Novo Nordisk Company Information
6.7.2 Novo Nordisk Description and Business Overview
6.7.3 Novo Nordisk Biosuperior Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Novo Nordisk Biosuperior Product Portfolio
6.7.5 Novo Nordisk Recent Developments/Updates
6.8 Biogen
6.8.1 Biogen Company Information
6.8.2 Biogen Description and Business Overview
6.8.3 Biogen Biosuperior Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Biogen Biosuperior Product Portfolio
6.8.5 Biogen Recent Developments/Updates
6.9 CSL Behring GmbH
6.9.1 CSL Behring GmbH Company Information
6.9.2 CSL Behring GmbH Description and Business Overview
6.9.3 CSL Behring GmbH Biosuperior Sales, Revenue and Gross Margin (2020-2025)
6.9.4 CSL Behring GmbH Biosuperior Product Portfolio
6.9.5 CSL Behring GmbH Recent Developments/Updates
6.10 Teva
6.10.1 Teva Company Information
6.10.2 Teva Description and Business Overview
6.10.3 Teva Biosuperior Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Teva Biosuperior Product Portfolio
6.10.5 Teva Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Biosuperior Industry Chain Analysis
7.2 Biosuperior Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Biosuperior Production Mode & Process Analysis
7.4 Biosuperior Sales and Marketing
7.4.1 Biosuperior Sales Channels
7.4.2 Biosuperior Distributors
7.5 Biosuperior Customer Analysis
8 Biosuperior Market Dynamics
8.1 Biosuperior Industry Trends
8.2 Biosuperior Market Drivers
8.3 Biosuperior Market Challenges
8.4 Biosuperior Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
F. Hoffmann-La Roche AG
Merck and Co.
Sanofi
Servier
Porton Biopharma
Eli Lily And Company
Novo Nordisk
Biogen
CSL Behring GmbH
TEVA
List of Tables
 Table 1. Global Biosuperior Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Biosuperior Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Biosuperior Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Biosuperior Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Biosuperior Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Biosuperior Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Biosuperior Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Biosuperior Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Biosuperior, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Biosuperior, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Biosuperior, Product Type & Application
 Table 12. Global Key Manufacturers of Biosuperior, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Biosuperior by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biosuperior as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Biosuperior Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Biosuperior Sales by Region (2020-2025) & (K Units)
 Table 18. Global Biosuperior Sales Market Share by Region (2020-2025)
 Table 19. Global Biosuperior Sales by Region (2026-2031) & (K Units)
 Table 20. Global Biosuperior Sales Market Share by Region (2026-2031)
 Table 21. Global Biosuperior Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Biosuperior Revenue Market Share by Region (2020-2025)
 Table 23. Global Biosuperior Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Biosuperior Revenue Market Share by Region (2026-2031)
 Table 25. North America Biosuperior Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Biosuperior Sales by Country (2020-2025) & (K Units)
 Table 27. North America Biosuperior Sales by Country (2026-2031) & (K Units)
 Table 28. North America Biosuperior Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Biosuperior Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Biosuperior Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Biosuperior Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Biosuperior Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Biosuperior Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Biosuperior Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Biosuperior Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Biosuperior Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Biosuperior Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Biosuperior Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Biosuperior Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Biosuperior Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Biosuperior Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Biosuperior Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Biosuperior Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Biosuperior Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Biosuperior Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Biosuperior Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Biosuperior Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Biosuperior Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Biosuperior Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Biosuperior Sales (K Units) by Type (2020-2025)
 Table 51. Global Biosuperior Sales (K Units) by Type (2026-2031)
 Table 52. Global Biosuperior Sales Market Share by Type (2020-2025)
 Table 53. Global Biosuperior Sales Market Share by Type (2026-2031)
 Table 54. Global Biosuperior Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Biosuperior Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Biosuperior Revenue Market Share by Type (2020-2025)
 Table 57. Global Biosuperior Revenue Market Share by Type (2026-2031)
 Table 58. Global Biosuperior Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Biosuperior Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Biosuperior Sales (K Units) by Application (2020-2025)
 Table 61. Global Biosuperior Sales (K Units) by Application (2026-2031)
 Table 62. Global Biosuperior Sales Market Share by Application (2020-2025)
 Table 63. Global Biosuperior Sales Market Share by Application (2026-2031)
 Table 64. Global Biosuperior Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Biosuperior Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Biosuperior Revenue Market Share by Application (2020-2025)
 Table 67. Global Biosuperior Revenue Market Share by Application (2026-2031)
 Table 68. Global Biosuperior Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Biosuperior Price (US$/Unit) by Application (2026-2031)
 Table 70. F.Hoffmann-La Roche AG Company Information
 Table 71. F.Hoffmann-La Roche AG Description and Business Overview
 Table 72. F.Hoffmann-La Roche AG Biosuperior Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. F.Hoffmann-La Roche AG Biosuperior Product
 Table 74. F.Hoffmann-La Roche AG Recent Developments/Updates
 Table 75. Merck and Co. Company Information
 Table 76. Merck and Co. Description and Business Overview
 Table 77. Merck and Co. Biosuperior Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Merck and Co. Biosuperior Product
 Table 79. Merck and Co. Recent Developments/Updates
 Table 80. Sanofi Company Information
 Table 81. Sanofi Description and Business Overview
 Table 82. Sanofi Biosuperior Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Sanofi Biosuperior Product
 Table 84. Sanofi Recent Developments/Updates
 Table 85. SERVIER Company Information
 Table 86. SERVIER Description and Business Overview
 Table 87. SERVIER Biosuperior Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. SERVIER Biosuperior Product
 Table 89. SERVIER Recent Developments/Updates
 Table 90. Porton Biopharma Company Information
 Table 91. Porton Biopharma Description and Business Overview
 Table 92. Porton Biopharma Biosuperior Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Porton Biopharma Biosuperior Product
 Table 94. Porton Biopharma Recent Developments/Updates
 Table 95. Eli Lily and Company Company Information
 Table 96. Eli Lily and Company Description and Business Overview
 Table 97. Eli Lily and Company Biosuperior Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Eli Lily and Company Biosuperior Product
 Table 99. Eli Lily and Company Recent Developments/Updates
 Table 100. Novo Nordisk Company Information
 Table 101. Novo Nordisk Description and Business Overview
 Table 102. Novo Nordisk Biosuperior Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Novo Nordisk Biosuperior Product
 Table 104. Novo Nordisk Recent Developments/Updates
 Table 105. Biogen Company Information
 Table 106. Biogen Description and Business Overview
 Table 107. Biogen Biosuperior Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Biogen Biosuperior Product
 Table 109. Biogen Recent Developments/Updates
 Table 110. CSL Behring GmbH Company Information
 Table 111. CSL Behring GmbH Description and Business Overview
 Table 112. CSL Behring GmbH Biosuperior Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. CSL Behring GmbH Biosuperior Product
 Table 114. CSL Behring GmbH Recent Developments/Updates
 Table 115. Teva Company Information
 Table 116. Teva Description and Business Overview
 Table 117. Teva Biosuperior Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Teva Biosuperior Product
 Table 119. Teva Recent Developments/Updates
 Table 120. Key Raw Materials Lists
 Table 121. Raw Materials Key Suppliers Lists
 Table 122. Biosuperior Distributors List
 Table 123. Biosuperior Customers List
 Table 124. Biosuperior Market Trends
 Table 125. Biosuperior Market Drivers
 Table 126. Biosuperior Market Challenges
 Table 127. Biosuperior Market Restraints
 Table 128. Research Programs/Design for This Report
 Table 129. Key Data Information from Secondary Sources
 Table 130. Key Data Information from Primary Sources
 Table 131. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Biosuperior
 Figure 2. Global Biosuperior Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Biosuperior Market Share by Type: 2024 & 2031
 Figure 4. G-CSF Biobetters Product Picture
 Figure 5. Insulin Biobetters Product Picture
 Figure 6. Erythropoietin Biobetters Product Picture
 Figure 7. Monoclonal Antibodies Biobetters Product Picture
 Figure 8. Others Product Picture
 Figure 9. Global Biosuperior Market Value by Application (2020-2031) & (US$ Million)
 Figure 10. Global Biosuperior Market Share by Application: 2024 & 2031
 Figure 11. Cancer
 Figure 12. Diabetes
 Figure 13. Genetic Disease
 Figure 14. Neurological Disorders
 Figure 15. Others
 Figure 16. Global Biosuperior Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 17. Global Biosuperior Market Size (2020-2031) & (US$ Million)
 Figure 18. Global Biosuperior Sales (2020-2031) & (K Units)
 Figure 19. Global Biosuperior Average Price (US$/Unit) & (2020-2031)
 Figure 20. Biosuperior Report Years Considered
 Figure 21. Biosuperior Sales Share by Manufacturers in 2024
 Figure 22. Global Biosuperior Revenue Share by Manufacturers in 2024
 Figure 23. Global 5 and 10 Largest Biosuperior Players: Market Share by Revenue in Biosuperior in 2024
 Figure 24. Biosuperior Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 25. Global Biosuperior Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 26. North America Biosuperior Sales Market Share by Country (2020-2031)
 Figure 27. North America Biosuperior Revenue Market Share by Country (2020-2031)
 Figure 28. United States Biosuperior Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Canada Biosuperior Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Europe Biosuperior Sales Market Share by Country (2020-2031)
 Figure 31. Europe Biosuperior Revenue Market Share by Country (2020-2031)
 Figure 32. Germany Biosuperior Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. France Biosuperior Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. U.K. Biosuperior Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Italy Biosuperior Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Russia Biosuperior Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Asia Pacific Biosuperior Sales Market Share by Region (2020-2031)
 Figure 38. Asia Pacific Biosuperior Revenue Market Share by Region (2020-2031)
 Figure 39. China Biosuperior Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Japan Biosuperior Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. South Korea Biosuperior Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. India Biosuperior Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Australia Biosuperior Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. China Taiwan Biosuperior Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Southeast Asia Biosuperior Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Latin America Biosuperior Sales Market Share by Country (2020-2031)
 Figure 47. Latin America Biosuperior Revenue Market Share by Country (2020-2031)
 Figure 48. Mexico Biosuperior Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Brazil Biosuperior Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Argentina Biosuperior Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Middle East and Africa Biosuperior Sales Market Share by Country (2020-2031)
 Figure 52. Middle East and Africa Biosuperior Revenue Market Share by Country (2020-2031)
 Figure 53. Turkey Biosuperior Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Saudi Arabia Biosuperior Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. UAE Biosuperior Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 56. Global Sales Market Share of Biosuperior by Type (2020-2031)
 Figure 57. Global Revenue Market Share of Biosuperior by Type (2020-2031)
 Figure 58. Global Biosuperior Price (US$/Unit) by Type (2020-2031)
 Figure 59. Global Sales Market Share of Biosuperior by Application (2020-2031)
 Figure 60. Global Revenue Market Share of Biosuperior by Application (2020-2031)
 Figure 61. Global Biosuperior Price (US$/Unit) by Application (2020-2031)
 Figure 62. Biosuperior Value Chain
 Figure 63. Channels of Distribution (Direct Vs Distribution)
 Figure 64. Bottom-up and Top-down Approaches for This Report
 Figure 65. Data Triangulation
 Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS

Biosimilars Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Biorationals and Biostimulants Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Generic vs Innovator Drugs Market Research Report 2024
Global Monoclonal antibodies mAbs Biosimilars Market Research Report 2024
Global Biorational Products Market Research Report 2024
Global Biosimilars and Innovative Biological Drugs Market Research Report 2024
Protein Biological Research Reagents Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Drugs of Bioengineered Protein Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Bio Stabilisers Market Research Report 2024
Global PGPR Bio stimulants Market Research Report 2024
Global Biologic Device Combination Products Market Research Report 2025
Global Biosimilar Antibodies Market Research Report 2024
Biosimilar Insulin Market
Global Biosimilar and Interchangeable Biologics Market Research Report 2024
Global Recombinant Protein Peptide Drug Market Research Report 2024
Biobetter Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Osteoporosis Biosimilars Market Research Report 2025
Global Biofertilizer Product Market Research Report 2025
Genetically Modified Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Biological Research Reagents Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Pharmacy Chatbot Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10T20319
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Inline Pharmaceutical Packaging Leak Detection System Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-6Q20319
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Radiological Marker Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35Z19949
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Pharmaceutical Biomanufacturing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-26E19785
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions